logo
科言猫学术研究的AI总结
language
手机端手机端
  • Phone Feature微信小程序
简体中文简体中文
notice消息通知
博客博客
arrow
A

Alexander M. Lesokhin

Memorial Sloan Kettering Cancer Center
H指数:56
被引数:2.4万

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Author Correction: FcRH5×CD3 bispecific antibody cevostamab in relapsed or refractory multiple myeloma: a phase 1 trial

作者更正：FcRH5×CD3 双特异性抗体 cevostamab 在复发或难治性多发性骨髓瘤中的研究：一项1期临床试验

Nature Medicine
IF50
2026-10-200
OAAI
Adam D. Cohen; Joshua Richter; Suzanne Trudel; Alexander Lesokhin; Jacob P. Laubach; Sheeba K. Thomas; Simon J. Harrison; Luciano J. Costa; Andrew Spencer; Rafael Fonseca; Peter A. Forsberg; Jesus G. Berdeja; Rayan Kaedbey; Nizar J. Bahlis; Paula Rodriguez-Otero; Maria-Victoria Mateos; Tulika Tyagi; Divya Samineni; Wenyu Liu; Rin Nakamura; Voleak Choeurng; Chihunt Wong; James Cooper; Amrita Krishnan
Dynamic risk stratification in smoldering multiple myeloma: Integrating evolving biomarkers with the 2/20/20 Model

动态风险分层在冒烟性多发性骨髓瘤中的应用：整合演变中的生物标志物与2/20/20模型

HemaSphere
IF14.6
2026-09-240
OAAI
Theresia Akhlaghi; David Nemirovsky; Kylee H. Maclachlan; Ross S. Firestone; Neha Korde; Sham Mailankody; Alexander M. Lesokhin; Hani Hassoun; Dhwani Patel; Urvi A. Shah; Carlyn R. Tan; Heather J. Landau; Gunjan L. Shah; Michael Scordo; Anish K. Simhal; Ola Landgren; Sergio A. Giralt; Saad Z. Usmani; Andriy Derkach; Malin Hultcrantz
Stem cell autograft minimal residual disease negativity and survival outcomes for multiple myeloma autotransplant

自体干细胞移植后微小残留病阴性及多发性骨髓瘤自体移植的生存结局

Blood Cancer Journal
IF11.6
2026-09-220
OAAI
Noriko Nishimura; Samantha Brown; Sarah Samorodnitsky; Sean M. Devlin; Mohammad Alhomoud; Parastoo Dahi; Charlotte Hughes; Eric Jergens; Heather J. Landau; Oscar B. Lahoud; Michael Scordo; Gunjan L. Shah; Ross Firestone; Hamza Hashmi; Hani Hassoun; Malin Hultcrantz; Neha Korde; Alexander M. Lesokhin; Kylee Maclachlan; Sham Mailankody; Francesco Maura; Maximilian Merz; Sridevi Rajeeve; Urvi A. Shah; Carlyn R. Tan; Gaurav K. Gupta; Elena Maryamchik; Evangelos Ntrivalas; Qi Gao; Mikhail Roshal; Saad Z. Usmani; Sergio A. Giralt; David J. Chung
Lesion-level PET/CT analysis to identify predictors of progression after BCMA CAR T-cell therapy in multiple myeloma

基于病灶水平的PET/CT分析以识别多发性骨髓瘤中BCMA CAR T细胞治疗后进展的预测因子

Blood Cancer Journal
IF11.6
2026-08-190
OAAI
Alexandra D. Dreyfuss; Joachim Yahalom; Sridevi Rajeeve; Alexander M. Lesokhin; Gunjan L. Shah; Heather J. Landau; Maximilian Merz; Michael Scordo; Andriy Derkach; David Nemirovsky; Harper Hubbeling; Gustav Cederquist; Zachary R. Moore; Sergio A. Giralt; Sham Mailankody; Saad Z. Usmani; Brandon S. Imber; Hamza Hashmi
Impact of granulocyte colony-stimulating factors on cytokine release syndrome during bispecific antibody initiation in relapsed/refractory multiple myeloma

粒细胞集落刺激因子对双特异性抗体启动期间细胞因子释放综合征的影响：在复发/难治性多发性骨髓瘤中的作用

Blood Cancer Journal
IF11.6
2026-08-070
OAAI
Alice X. Wang; Tala Shekarkhand; David Nemirovsky; Andriy Derkach; Carlyn R. Tan; Issam S. Hamadeh; Ross S. Firestone; Eric Jurgens; Kevin Miller; Dhwani Patel; Neha Korde; Alexander M. Lesokhin; Sham Mailankody; Hani Hassoun; Hamza Hashmi; Sridevi Rajeeve; Urvi A. Shah; Kylee Maclachlan; Gunjan L. Shah; Michael Scordo; Heather J. Landau; Sergio A. Giralt; Saad Z. Usmani; Malin Hultcrantz
Robust CD4+ CAR T cell expansion is associated with non-ICANS neurotoxicities after ciltacabtagene autoleucel in patients with multiple myeloma

在多发性骨髓瘤患者中，强效CD4+ CAR T细胞扩增与非ICANS神经毒性的发生相关（cilta-cel治疗）

Science Translational Medicine
IF14.6
2026-07-290
PRE
Eric M. Jurgens; Sneha Mitra; Kevin Herrera; David Nemirovsky; Brenden Bready; Andriy Derkach; Kinga Hosszu; Devin McAvoy; Ross S. Firestone; Sridevi Rajeeve; Alexander M. Lesokhin; Neha Korde; Carlyn R. Tan; Hamza Hashmi; Hani Hassoun; Kylee Maclachlan; Urvi A. Shah; Malin Hultcrantz; Maximilian Merz; Francesco Maura; Sergio A. Giralt; Gunjan L. Shah; Heather J. Landau; Michael Scordo; Ivan S. Kotchetkov; Bianca D. Santomasso; Jae Park; Christina S. Leslie; Saad Z. Usmani; Karlo Perica; Sham Mailankody
FcRH5×CD3 bispecific antibody cevostamab in relapsed or refractory multiple myeloma: a phase 1 trial

FcRH5×CD3双特异性抗体塞沃司单抗在复发或难治性多发性骨髓瘤中的应用：一项I期临床试验

Nature Medicine
IF50
2026-07-220
OAAI
Adam D. Cohen; Joshua Richter; Suzanne Trudel; Alexander Lesokhin; Jacob P. Laubach; Sheeba K. Thomas; Simon J. Harrison; Luciano J. Costa; Andrew Spencer; Rafael Fonseca; Peter A. Forsberg; Jesus G. Berdeja; Rayan Kaedbey; Nizar J. Bahlis; Paula Rodriguez-Otero; Maria-Victoria Mateos; Tulika Tyagi; Divya Samineni; Wenyu Liu; Rin Nakamura; Voleak Choeurng; Chihunt Wong; James Cooper; Amrita Krishnan
Functionally high-risk disease is associated with poor outcomes after late-line CAR T-cell therapy for multiple myeloma

功能性高风险疾病与多发性骨髓瘤晚期CAR T细胞疗法后的不良预后相关

Blood Cancer Journal
IF11.6
2026-04-120
OAAI
Hamza Hashmi; Tara Sebastian; Sridevi Rajeeve; Tasmin Farzana; Ross S. Firestone; Eric M. Jurgens; Kevin C. Miller; Francesco Maura; Alexander M. Lesokhin; Carlyn R. Tan; Gunjan L. Shah; Neha Korde; Heather J. Landau; Maximillian Merz; Michael Scordo; Hani Hassoun; Kylee H. Maclachlan; Urvi A. Shah; Malin L. Hultcrantz; Andriy Derkach; David Nemirovsky; Sergio Giralt; Sham Mailankody; Saad Z. Usmani
Dietary patterns among individuals with plasma cell disorders– opportunities for targeted interventions

血浆细胞障碍患者中的饮食模式——针对干预的机会

Blood Cancer Journal
IF11.6
2026-03-270
OAAI
Kadiatou Traore; Francesca Castro; Andriy Derkach; Elan Gorshein; Edith Serrano; Alankrita Taneja; Jorge Arturo Hurtado Martínez; Alexander M. Lesokhin; Ana M. Sahagun Sanchez Aldana; Patricia Alejandra Flores Pérez; Saad Z. Usmani; Jenifer M. Ahlstrom; Torin Block; Jay R. Hydren; Cynthia A. Thomson; Urvi A. Shah
IMS-IMWG 2025 consensus genomic staging predicts outcomes with daratumumab-based quadruplet regimens for NDMM

IMS-IMWG 2025年共识基因组分期可预测达雷木单抗为基础的四联方案对NDMM的疗效。

Blood Advances
IF7.1
2026-02-190
OAAI
Kylee H. Maclachlan; Carlyn R. Tan; Tala Shekarkhand; Colin Rueda; Andriy Derkach; Hamza Hashmi; Hani Hassoun; Urvi A. Shah; Malin Hultcrantz; Alexander M. Lesokhin; Sham Mailankody; Francesco Maura; Maximillian Merz; Ross Firestone; Eric M. Jurgens; Kevin C. Miller; Sridevi Rajeeve; Sergio Giralt; Gunjan L. Shah; Michael Scordo
Cytomegalovirus reactivation during treatment with bispecific antibodies for relapsed/refractory multiple myeloma

双特异性抗体治疗复发/难治性多发性骨髓瘤期间巨细胞病毒再激活

Blood Cancer Journal
IF11.6
2025-11-010
OAAI
Eric Jurgens; Tala Shekarkhand; Colin Rueda; David Nemirovsky; Andriy Derkach; Ross S. Firestone; Kevin Miller; Bruno Almeida Costa; Sridevi Rajeeve; Alexander M. Lesokhin; Neha Korde; Carlyn R. Tan; Hamza Hashmi; Hani Hassoun; Kylee Maclachlan; Urvi A. Shah; Malin Hultcrantz; Issam Hamadeh; Sergio A. Giralt; Gunjan L. Shah; Heather J. Landau; Michael Scordo; Saad Z. Usmani; Sham Mailankody; Zainab Shahid
Correction: Impact of daratumumab refractoriness on clinical outcomes following CAR T-cell therapy for relapsed refractory multiple myeloma

更正：达鲁珠单抗耐药性对复发难治性多发性骨髓瘤接受CAR T细胞治疗后临床结局的影响

Blood Cancer Journal
IF11.6
2025-10-130
OA
Tara Sebastian; Sridevi Rajeeve; Tasmin Farzana; Ross Firestone; Eric Jurgens; Kevin Miller; Bruno Almeida Costa; Alexander Lesokhin; Carlyn Rose Tan; Gunjan Shah; Neha Korde; Heather Landau; Michael Scordo; Hani Hassoun; Kylee Maclachlan; Urvi Shah; Malin Hultcrantz; Andriy Derkach; Derkach Nemirovsky; Sergio Giralt; Saad Usmani; Sham Mailankody; Hamza Hashmi
Temporal genomic dynamics shape clinical trajectory in multiple myeloma

时间基因组动力学塑造多发性骨髓瘤的临床轨迹

Nature Genetics
IF0
2025-08-200
OA
Francesco Maura; Marcella Kaddoura; Alexandra M. Poos; Linda B. Baughn; Bachisio Ziccheddu; Marc-Andrea Bärtsch; Anthony Cirrincione; Kylee Maclachlan; Monika Chojnacka; Benjamin Diamond; Marios Papadimitriou; Patrick Blaney; Lukas John; Philipp Reichert; Stefanie Huhn; Dylan Gagler; Yanming Zhang; Ahmet Dogan; Alexander M. Lesokhin; Faith Davies; Hartmut Goldschmidt; Roland Fenk; Katja C. Weisel; Elias K. Mai; Neha Korde; Gareth J. Morgan; S. Vincent Rajkumar; Shaji Kumar; Saad Usmani; Ola Landgren; Marc S. Raab; Niels Weinhold
Impact of daratumumab refractoriness on clinical outcomes following CAR T-cell therapy for relapsed refractory multiple myeloma

daratumumab难治性对复发性难治性多发性骨髓瘤CAR T细胞治疗后临床结局的影响

Blood Cancer Journal
IF11.6
2025-08-140
OAAI
T. Sebastian; S. Rajeeve; T. Farzana; R. Firestone; E. Jurgens; K. Miller; B. Costa; A. Lesokhin; C. Tan; G. Shah; N. Korde; H. Landau; M. Scordo; H. Hassoun; K. Maclachlan; U. Shah; M. Hultcrantz; A. Derkach; D. Nemirovsky; S. Giralt; S. Z. Usmani; S. Mailankody; H. Hashmi
Humoral vaccine responses following Chimeric Antigen Receptor T-cell therapy for hematological malignancies

嵌合抗原受体T细胞疗法治疗血液系统恶性肿瘤后的体液疫苗反应

Blood Cancer Journal
IF11.6
2025-07-020
OAAI
Sigrun Einarsdottir; Stephanie Lobaugh; Danny Luan; Marina Gomez-Llobell; Padmapriya Subramanian; Sean Devlin; David Chung; Parastoo B. Dahi; Lorenzo Falchi; Sergio Giralt; Heather Landau; Alexander M. Lesokhin; Richard Lin; Jennifer Lue; Sham Mailankody; M. Lia Palomba; Jae H. Park; Gilles Salles; Michael Scordo; Silvia Escribano-Serrat; Jaime Sanz; Kai Rejeski; Roni Shouval; Saad Usmani; Miguel-Angel Perales; Gunjan Shah; Zainab Shahid
Outcomes in frail patients receiving BCMA-directed bispecific antibodies for relapsed/refractory multiple myeloma

老年体弱患者接受BCMA靶向双特异性抗体治疗复发/难治性多发性骨髓瘤的结局

Blood Advances
IF7.1
2025-05-060
OA
Benjamin Adegbite; Carlyn Rose Tan; Tala Shekarkhand; Ross S. Firestone; Eric M. Jurgens; Kevin Miller; Alexander M. Lesokhin; Gunjan L. Shah; Neha Korde; Sridevi Rajeeve; Heather J. Landau; Michael Scordo; Hani Hassoun; Kylee H. Maclachlan; Urvi A. Shah; Malin Hultcrantz; Issam S. Hamadeh; Andriy Derkach; David Nemirovsky; Sergio A. Giralt; Sham Mailankody; Saad Z. Usmani; Hamza Hashmi
Restarting teclistamab and talquetamab after prolonged dose delay may not require re–step-up dosing

在长期剂量延迟后重新开始teclistamab和talquetamab治疗，可能不需要重新进行剂量递增。

Blood Advances
IF7.1
2025-03-100
OA
Carlyn Rose Tan; Alice Wang; David Nemirovsky; Andriy Derkach; Tala Shekarkhand; Issam Hamadeh; Kylee Maclachlan; Malin Hultcrantz; Hani Hassoun; Sham Mailankody; Alexander Lesokhin; Urvi A. Shah; Sridevi Rajeeve; Hamza Hashmi; Dhwani Patel; Ross Firestone; Eric Jurgens; Kevin Miller; Gunjan L. Shah; Michael Scordo; Saad Z. Usmani
Biomarker Correlates and Clinical Activity of Cevostamab in Patients (pts) with Triple-Class Refractory Multiple Myeloma (MM) Who Have Received ≥1 Prior B-Cell Maturation Antigen (BCMA)-Targeted Bispecific Antibody (BsAb): Results from the Phase I/II CAMMA 2 Study

三药耐药多发性骨髓瘤（MM）患者中Cevostamab的生物标志物相关性及临床活性：这些患者已接受≥1种既往B细胞成熟抗原（BCMA）靶向双特异性抗体（BsAb）；结果来自I/II期CAMMA 2研究

BLOOD
IF23.1
2024-11-050
PRE
Delforge, Michel; Richter, Joshua; Cohen, Yael C.; Corradini, Paolo; Sborov, Douglas W.; Lesokhin, Alexander M.; Berdeja, Jesus G.; Gatt, Moshe E.; Paris, Laura; Dachs, Laura Rosinol; Quach, Hang; Kanwar, Manisha; Catalani, Olivier; Sewpaul, Paresh; Wassner-Fritsch, Elisabeth; Mishra, Ameet; Trunzer, Kerstin; Kumar, Shaji

研究方向

暂未获取到该数据
S
Sham Mailankody
H 指数:47论文数:455被引数:8,504
U
Urvi A. Shah
H 指数:32论文数:379被引数:4,154
M
Malin Hultcrantz
H 指数:43论文数:439被引数:6,954
S
Saad Z. Usmani
H 指数:85论文数:1,145被引数:3.9万
N
Neha Korde
H 指数:40论文数:447被引数:5,875
H
Hani Hassoun
H 指数:47论文数:415被引数:9,010
K
Kylee Maclachlan
H 指数:19论文数:331被引数:1,744
C
Carlyn Tan
H 指数:26论文数:257被引数:3,169
G
Gunjan L. Shah
H 指数:43论文数:663被引数:8,077
S
Sergio Giralt
H 指数:122论文数:1,814被引数:6.2万